Original Research
Published on 13 Feb 2026
A real-world study of ublituximab based on the WHO-VigiAccess and U.S. food and drug administration’s adverse event reporting system databases
in Multiple Sclerosis and Neuroimmunology
- 369 views
Original Research
Published on 13 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Feb 2026
in Sport Psychology
Original Research
Published on 13 Feb 2026
in Public Health Education and Promotion
Original Research
Published on 13 Feb 2026
in Geriatric Medicine
Original Research
Published on 13 Feb 2026
in Molecular Innate Immunity
Systematic Review
Published on 13 Feb 2026
in Public Mental Health
Correction
Published on 13 Feb 2026
in Sustainable Energy Systems
Original Research
Published on 13 Feb 2026
in Functional and Applied Plant Genomics
Original Research
Published on 13 Feb 2026
in Nanoscience
Original Research
Published on 13 Feb 2026
in Neuro-Otology
Original Research
Published on 13 Feb 2026
in Livestock Genomics
Review
Published on 13 Feb 2026
in Extra-intestinal Microbiome
Original Research
Published on 13 Feb 2026
in Sport Psychology
Case Report
Published on 13 Feb 2026
in Obstetrics and Gynecology
Editorial
Published on 13 Feb 2026
in Neuropharmacology
Correction
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy